Finance

Beta
Lists
300119:SHE
Tianjin Ringpu Bio-Technology Co Ltd
CN¥15.35
-1.22%
(-0.19) 1D
Jun 9, 3:04:22 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300119...
Open
CN¥15.56
High
CN¥15.65
Low
CN¥15.24
Mkt. cap
7.35B
Avg. vol.
3.42M
Volume
2.82M
Dividend
2.61%
Quarterly dividend
CN¥0.10
Ex-dividend date
May 13, 2026
P/E ratio
17.95
52-wk high
CN¥24.03
52-wk low
CN¥15.24
EPS
CN¥0.86
Shares outstanding
464.75M
No. of employees
3K
Open
CN¥15.56
High
CN¥15.65
Low
CN¥15.24
Mkt. cap
7.35B
Avg. vol.
3.42M
Volume
2.82M
Dividend
2.61%
Quarterly dividend
CN¥0.10
Ex-dividend date
May 13, 2026
P/E ratio
17.95
52-wk high
CN¥24.03
52-wk low
CN¥15.24
EPS
CN¥0.86
Shares outstanding
464.75M
No. of employees
3K
News stories
From sources across the web
About Tianjin Ringpu Bio-Technology Co Ltd
CEO-
Employees2.8K
Founded1998
Headquarters-
SectorPharmaceutical industry
Websiteringpu.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
885.97M
836.74M
854.13M
826.13M
Cost of goods sold
506.73M
486.26M
527.91M
497.91M
Cost of revenue
506.73M
486.26M
527.91M
497.91M
Research and development expenses
55.47M
53.61M
94.71M
45.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
189.44M
185.22M
184.65M
144.66M
Operating expense
250.75M
236.31M
304.33M
204.46M
Total operating expenses
757.48M
722.57M
832.24M
702.37M
Operating income
128.49M
114.16M
21.89M
123.75M
Other non operating income
-3.17M
375.87K
-4.59M
-1.05M
EBT including unusual items
176.08M
129.00M
30.18M
128.46M
EBT excluding unusual items
149.05M
133.91M
-15.83M
124.19M
Income tax expense
24.12M
10.27M
-13.50M
11.05M
Effective tax rate
13.70%
7.96%
-44.72%
8.61%
Other operating expenses
6.92M
-6.51M
18.54M
4.09M
Net income
140.54M
105.78M
38.21M
107.78M
Net profit margin
15.86%
12.64%
4.47%
13.05%
Earnings per share
-
-
-
-
Interest and investment income
32.72M
28.41M
-
9.65M
Interest expense
-9.18M
-8.85M
-32.99M
-8.16M
Net interest expenses
23.54M
19.56M
-32.99M
1.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
182.17M
162.26M
74.51M
176.38M
Gain or loss from assets sale
-3.73M
3.73M
-3.82M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more